Companies set to double Remdesivir output

Credit: IndiaTimes- Published on April 13, 2021
Even as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddyโ€™s are ramping up production, which could see a doubling of overall industry capacity over the next few months.

Video credit: ANI
Published on April 16, 2021 -  01:29
Strict action against those involved in black marketing of Remdesivir: Health Minister
Union Health Minister Dr Harsh Vardhan on April 16 said that strict action would be taken against those involved in black marketing of the Remdesivir drug. "Companies manufacturing COVID-19 drug Remdesivir have been asked to ramp up production. I assure you that strict action will be taken against those who are involved in black marketing of the drug and other malpractices," said Health Minister.

You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions


COVID-19

Disease caused by severe acute respiratory syndrome coronavirus 2
The inhabitants of โ€˜Sainikโ€™ Girgaon, a small village in Karveer taluka of Kolhpur district, have started a 100-bed Covid care centre in a school on their..
Credit: IndiaTimes - Published 4 hours ago

The Uttarakhand state health department has issued a notice to Baba Barfani Hospital in Haridwar โ€” set up as a dedicated Covid healthcare centre to cater to..
Credit: IndiaTimes - Published 4 hours ago

Increasing cases and deaths due to secondary infection in hospitals along with rising incidence of mucormycosis among Covid-19 patients are being reported from..
Credit: IndiaTimes - Published 5 hours ago

The younger brother of West Bengal CM Mamata Banerjee, Ashim Banerjee, 62, died on Saturday due to Covid-related complications. He resided in the same house as..
Credit: IndiaTimes - Published 5 hours ago

RSS chief Mohan Bhagwat on Saturday attributed the current surge of Covid infections to the complacency which had set in among people, the government and the..
Credit: IndiaTimes - Published 6 hours ago



Related news from verified sources

Even as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr...
on April 13, 2021 • IndiaTimes

You might like